1. Ohye, RG, Schranz, D, D’Udekem, Y. Current therapy for hypoplastic left heart syndrome and related single ventricle lesions. Circulation 2016; 134: 1265–1279.
2. Morris, SA, Ethen, MK, Penny, DJ, et al. Prenatal diagnosis, birth location, surgical center, and neonatal mortality in infants with hypoplastic left heart syndrome. Circulation 2014; 129: 285–292.
3. Atz, AM, Travison, TG, Williams, IA, et al. Prenatal diagnosis and risk factors for preoperative death in neonates with single right ventricle and systemic outflow obstruction: Screening data from the pediatric heart network single ventricle reconstruction trial(*). J Thorac Cardiovasc Surg 2010; 140: 1245–1250.
4. van Velzen, CL, Clur, SA, Rijlaarsdam, ME, et al. Prenatal detection of congenital heart disease--results of a national screening programme. BJOG 2016; 123: 400–407.
5. Donofrio, MT, Moon-Grady, AJ, Hornberger, LK, et al. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American heart association. Circulation 2014; 129: 2183–2242.
6. Patel, A, Hickey, E, Mavroudis, C, et al. Impact of noncardiac congenital and genetic abnormalities on outcomes in hypoplastic left heart syndrome. Ann Thorac Surg 2010; 89: 1805–1813; discussion 1813–1804.
7. Beroukhim, RS, Gauvreau, K, Benavidez, OJ, Baird, CW, LaFranchi, T, Tworetzky, W. Perinatal outcome after prenatal diagnosis of single-ventricle cardiac defects. Ultrasound Obstet Gynecol 2015; 45: 657–663.
8. Rychik, J, Szwast, A, Natarajan, S, et al. Perinatal and early surgical outcome for the fetus with hypoplastic left heart syndrome: a 5-year single institutional experience. Ultrasound Obstet Gynecol 2010; 36: 465–470.
9. Kipps, AK, Feuille, C, Azakie, A, et al. Prenatal diagnosis of hypoplastic left heart syndrome in current era. Am J Cardiol 2011; 108: 421–427.
10. Freud, LR, McElhinney, DB, Marshall, AC, et al. Fetal aortic valvuloplasty for evolving hypoplastic left heart syndrome: Postnatal outcomes of the first 100 patients. Circulation 2014; 130: 638–645.
11. Moon-Grady, AJ, Morris, SA, Belfort, M, et al. International fetal cardiac intervention registry: A worldwide collaborative description and preliminary outcomes. J Am Coll Cardiol 2015; 66: 388–399.
12. Emani, SM, McElhinney, DB, Tworetzky, W, et al. Staged left ventricular recruitment after single-ventricle palliation in patients with borderline left heart hypoplasia. J Am Coll Cardiol 2012; 60: 1966–1974.
13. Marshall, AC, Levine, J, Morash, D, et al. Results of in utero atrial septoplasty in fetuses with hypoplastic left heart syndrome. Prenat Diagn 2008; 28: 1023–1028.
14. Kalish, BT, Tworetzky, W, Benson, CB, et al. Technical challenges of atrial septal stent placement in fetuses with hypoplastic left heart syndrome and intact atrial septum. Catheter Cardiovasc Interv 2014; 84: 77–85.
15. Lara, DA, Morris, SA, Maskatia, SA, et al. Pilot study of chronic maternal hyperoxygenation and effect on aortic and mitral valve annular dimensions in fetuses with left heart hypoplasia. Ultrasound Obstet Gynecol 2016; 48: 365–372.
16. Sun, L, Macgowan, CK, Sled, JG, et al. Reduced fetal cerebral oxygen consumption is associated with smaller brain size in fetuses with congenital heart disease. Circulation 2015; 131: 1313–1323.
17. Limperopoulos, C, Tworetzky, W, McElhinney, DB, et al. Brain volume and metabolism in fetuses with congenital heart disease: Evaluation with quantitative magnetic resonance imaging and spectroscopy. Circulation 2010; 121: 26–33.
18. Jones, HN, Olbrych, SK, Smith, KL, et al. Hypoplastic left heart syndrome is associated with structural and vascular placental abnormalities and leptin dysregulation. Placenta 2015; 36: 1078–1086.
19. Williams, RV, Ravishankar, C, Zak, V, et al. Birth weight and prematurity in infants with single ventricle physiology: Pediatric heart network infant single ventricle trial screened population. Congenit Heart Dis 2010; 5: 96–103.
20. Costello, JM, Pasquali, SK, Jacobs, JP, et al. Gestational age at birth and outcomes after neonatal cardiac surgery: An analysis of the society of thoracic surgeons congenital heart surgery database. Circulation 2014; 129: 2511–2517.
21. Costello, JM, Polito, A, Brown, DW, et al. Birth before 39 weeks’ gestation is associated with worse outcomes in neonates with heart disease. Pediatrics 2010; 126: 277–284.
22. Calderon, J, Stopp, C, Wypij, D, et al. Early-term birth in single-ventricle congenital heart disease after the fontan procedure: Neurodevelopmental and psychiatric outcomes. J Pediatr 2016; 179: 96–103.
23. Brown, DW, Cohen, KE, O’Brien, P, et al. Impact of prenatal diagnosis in survivors of initial palliation of single ventricle heart disease: analysis of the national pediatric cardiology quality improvement collaborative database. Pediatr Cardiol 2015; 36: 314–321.
24. Allen, RH, Benson, CB, Haug, LW. Pregnancy outcome of fetuses with a diagnosis of hypoplastic left ventricle on prenatal sonography. J Ultrasound Med 2005; 24: 1199–1203.
25. Thakur, V, Munk, N, Mertens, L, Nield, LE. Does prenatal diagnosis of hypoplastic left heart syndrome make a difference? – a systematic review. Prenat Diagn 2016; 36: 854–863.
26. Hornik, CP, He, X, Jacobs, JP, et al. Relative impact of surgeon and center volume on early mortality after the norwood operation. Ann Thorac Surg 2012; 93: 1992–1997.
27. Pasquali, SK, Jacobs, JP, He, X, et al. The complex relationship between center volume and outcome in patients undergoing the norwood operation. Ann Thorac Surg 2012; 93: 1556–1562.
28. Norwood, WI, Lang, P, Casteneda, AR, Campbell, DN. Experience with operations for hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 1981; 82: 511–519.
29. Karamlou, T, Peyvandi, S. Hybrid versus norwood: “Fifty shades of grey”. J Thorac Cardiovasc Surg 2015; 150: 456–457.
30. Caldarone, CA, Benson, L, Holtby, H, Li, J, Redington, AN, Van Arsdell, GS. Initial experience with hybrid palliation for neonates with single-ventricle physiology. Ann Thorac Surg 2007; 84: 1294–1300.
31. O’Brien, SM, Clarke, DR, Jacobs, JP, et al. An empirically based tool for analyzing mortality associated with congenital heart surgery. J Thorac Cardiovasc Surg 2009; 138: 1139–1153.
32. Kogon, BE, Kanter, K, Alsoufi, B, Maher, K, Oster, ME. Outcomes and hospital costs associated with the norwood operation: Beyond morbidity and mortality. Cardiol Young 2015; 25: 853–859.
33. McHugh, KE, Pasquali, SK, Hall, MA, Scheurer, MA. Impact of postoperative complications on hospital costs following the norwood operation. Cardiol Young 2016; 26: 1303–1309.
34. Noonan, JA, Nadas, AS. The hypoplastic left heart syndrome; an analysis of 101 cases. Pediatr Clin North Am 1958; 5: 1029–1056.
35. Norwood, WI, Lang, P, Hansen, DD. Physiologic repair of aortic atresia-hypoplastic left heart syndrome. N Engl J Med 1983; 308: 23–26.
36. Egan, MJ, Hill, SL, Boettner, BL, Holzer, RJ, et al. Predictors of retrograde aortic arch obstruction after hybrid palliation of hypoplastic left heart syndrome. Pediatr Cardiol 2011; 32: 67–75.
37. Barnea, O, Santamore, WP, Rossi, A, Salloum, E, Chien, S, Austin, EH. Estimation of oxygen delivery in newborns with a univentricular circulation. Circulation 1998; 98: 1407–1413.
38. Pizarro, C, Malec, E, Maher, KO, et al. Right ventricle to pulmonary artery conduit improves outcome after stage i norwood for hypoplastic left heart syndrome. Circulation 2003; 108 (Suppl 1): II155–II160.
39. Wright, GE, Crowley, DC, Charpie, JR, Ohye, RG, Bove, EL, Kulik, TJ. High systemic vascular resistance and sudden cardiovascular collapse in recovering norwood patients. Ann Thorac Surg 2004; 77: 48–52.
40. Ohye, RG, Ludomirsky, A, Devaney, EJ, Bove, EL. Comparison of right ventricle to pulmonary artery conduit and modified Blalock-Taussig shunt hemodynamics after the norwood operation. Ann Thorac Surg 2004; 78: 1090–1093.
41. Sano, S, Ishino, K, Kawada, M, Arai, S, et al. Right ventricle-pulmonary artery shunt in first-stage palliation of hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 2003; 126: 504–509; discussion 509–510.
42. Karamlou, T, Overman, D, Hill, KD, et al. Stage 1 hybrid palliation for hypoplastic left heart syndrome – assessment of contemporary patterns of use: An analysis of the society of thoracic surgeons congenital heart surgery database. J Thorac Cardiovasc Surg 2015; 149: 195–201; 202 e191.
43. Gibbs, JL, Rothman, MT, Rees, MR, Parsons, JM, Blackburn, ME, Ruiz, CE. Stenting of the arterial duct: a new approach to palliation for pulmonary atresia. Br Heart J 1992; 67: 240–245.
44. Ohye, RG, Gaynor, JW, Ghanayem, NS, et al. Design and rationale of a randomized trial comparing the blalock-taussig and right ventricle-pulmonary artery shunts in the norwood procedure. J Thorac Cardiovasc Surg 2008; 136: 968–975.
45. Ohye, RG, Sleeper, LA, Mahony, L, et al
. Comparison of shunt types in the norwood procedure for single-ventricle lesions. N Engl J Med 2010; 362: 1980–1992.
46. Newburger, JW, Sleeper, LA, Frommelt, PC, et al. Transplantation-free survival and interventions at 3 years in the single ventricle reconstruction trial. Circulation 2014; 129: 2013–2020.
47. Vida, VL, Bacha, EA, Larrazabal, A, et al. Surgical outcome for patients with the mitral stenosis-aortic atresia variant of hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 2008; 135: 339–346.
48. Siehr, SL, Maeda, K, Connolly, AA, et al. Mitral stenosis and aortic atresia--a risk factor for mortality after the modified norwood operation in hypoplastic left heart syndrome. Ann Thorac Surg 2016; 101: 162–167.
49. Sata, S, Sinzobahamvya, N, Arenz, C, Zartner, P, Asfour, B, Hraska, V. Restrictive atrial septum defect becomes a risk factor for norwood palliation of hypoplastic left heart syndrome only when it is combined with mitral or aortic atresia. Thorac Cardiovasc Surg 2015; 63: 354–359.
50. Alsoufi, B, Mori, M, Gillespie, S, et al. Impact of patient characteristics and anatomy on results of norwood operation for hypoplastic left heart syndrome. Ann Thorac Surg 2015; 100: 591–598.
51. Kalfa, D, Krishnamurthy, G, Levasseur, S, et al. Norwood stage i palliation in patients less than or equal to 2.5 kg: Outcomes and risk analysis. Ann Thorac Surg 2015; 100: 167–173.
52. Shamszad, P, Gospin, TA, Hong, BJ, McKenzie, ED, Petit, CJ. Impact of preoperative risk factors on outcomes after norwood palliation for hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 2014; 147: 897–901.
53. Tabbutt, S, Ghanayem, N, Ravishankar, C, et al. Risk factors for hospital morbidity and mortality after the norwood procedure: A report from the pediatric heart network single ventricle reconstruction trial. J Thorac Cardiovasc Surg 2012; 144: 882–895.
54. Alsoufi, B, Manlhiot, C, Al-Ahmadi, M, et al. Older children at the time of the norwood operation have ongoing mortality vulnerability that continues after cavopulmonary connection. J Thorac Cardiovasc Surg 2011; 142: 142–147 e142.
55. Lynch, JM, Buckley, EM, Schwab, PJ, et al. Time to surgery and preoperative cerebral hemodynamics predict postoperative white matter injury in neonates with hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 2014; 148: 2181–2188.
56. Taeed, R, Schwartz, SM, Pearl, JM, et al. Unrecognized pulmonary venous desaturation early after norwood palliation confounds gp:Gs assessment and compromises oxygen delivery. Circulation 2001; 103: 2699–2704.
57. Gupta, P, Jacobs, JP, Pasquali, SK, et al. Epidemiology and outcomes after in-hospital cardiac arrest after pediatric cardiac surgery. Ann Thorac Surg 2014; 98: 2138–2143; discussion 2144.
58. Marino, BS, Tabbutt, S, MacLaren, G, et al. Cardiopulmonary resuscitation in infants and children with cardiac disease: A scientific statement from the American heart association. Circulation 2018; 137: e691–e782.
59. Sherwin, ED, Gauvreau, K, Scheurer, MA, et al. Extracorporeal membrane oxygenation after stage 1 palliation for hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 2012; 144: 1337–1343.
60. Allan, CK, Thiagarajan, RR, del Nido, PJ, Roth, SJ, Almodovar, MC, Laussen, PC. Indication for initiation of mechanical circulatory support impacts survival of infants with shunted single-ventricle circulation supported with extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg 2007; 133: 660–667.
61. Jaggers, JJ, Forbess, JM, Shah, AS, et al. Extracorporeal membrane oxygenation for infant postcardiotomy support: Significance of shunt management. Ann Thorac Surg 2000; 69: 1476–1483.
62. Roeleveld, PP, Wilde, R, Hazekamp, M, Rycus, PT, Thiagarajan, RR. Extracorporeal membrane oxygenation in single ventricle lesions palliated via the hybrid approach. World J Pediatr Congenit Heart Surg 2014; 5: 393–397.
63. Polimenakos, AC, Rizzo, V, El-Zein, CF, Ilbawi, MN. Post-cardiotomy rescue extracorporeal cardiopulmonary resuscitation in neonates with single ventricle after intractable cardiac arrest: Attrition after hospital discharge and predictors of outcome. Pediatr Cardiol 2017; 38: 314–323.
64. Friedland-Little, JM, Uzark, K, Yu, S, Lowery, R, Aiyagari, R, Hirsch-Romano, JC. Functional status and quality of life in survivors of extracorporeal membrane oxygenation after the norwood operation. Ann Thorac Surg 2017; 103: 1950–1955.
65. Elias, MD, Achuff, BJ, Ittenbach, RF, et al. Long-term outcomes of pediatric cardiac patients supported by extracorporeal membrane oxygenation. Pediatr Crit Care Med 2017; 18: 787–794.
66. Poh, CL, Chiletti, R, Zannino, D, et al. Ventricular assist device support in patients with single ventricles: The melbourne experience. Interact Cardiovasc Thorac Surg. 2017; 25: 310–316.
67. Pasquali, SK, Ohye, RG, Lu, M, et al. Variation in perioperative care across centers for infants undergoing the norwood procedure. J Thorac Cardiovasc Surg 2012; 144: 915–921.
68. Feinstein, JA, Benson, DW, Dubin, AM, et al. Hypoplastic left heart syndrome: Current considerations and expectations. J Am Coll Cardiol 2012; 59: S1–S42.
69. Jeffries, HE, Wells, WJ, Starnes, VA, Wetzel, RC, Moromisato, DY. Gastrointestinal morbidity after norwood palliation for hypoplastic left heart syndrome. Ann Thorac Surg 2006; 81: 982–987.
70. Oster, ME, Chen, S, Dagincourt, N, et al. Development and impact of arrhythmias after the norwood procedure: A report from the pediatric heart network. J Thorac Cardiovasc Surg 2017; 153 (638-645): e632.
71. Kogon, B, Jain, A, Oster, M, Woodall, K, Kanter, K, Kirshbom, P. Risk factors associated with readmission after pediatric cardiothoracic surgery. Ann Thorac Surg 2012; 94: 865–873.
72. Ugonabo, N, Hirsch-Romano, JC, Uzark, K. The role of home monitoring in interstage management of infants following the norwood procedure. World J Pediatr Congenit Heart Surg 2015; 6: 266–273.
73. Pridjian, AK, Mendelsohn, AM, Lupinetti, FM, et al. Usefulness of the bidirectional Glenn procedure as staged reconstruction for the functional single ventricle. Am J Cardiol 1993; 71: 959–962.
74. Kirklin, JK, Blackstone, EH, Kirklin, JW, Pacifico, AD, Bargeron, LM Jr. The fontan operation. Ventricular hypertrophy, age, and date of operation as risk factors. J Thorac Cardiovasc Surg 1986; 92: 1049–1064.
75. Seliem, MA, Baffa, JM, Vetter, JM, Chen, SL, Chin, AJ, Norwood, WI Jr. Changes in right ventricular geometry and heart rate early after hemi-fontan procedure. Ann Thorac Surg 1993; 55: 1508–1512.
76. Fogel, MA, Weinberg, PM, Chin, AJ, Fellows, KE, Hoffman, EA. Late ventricular geometry and performance changes of functional single ventricle throughout staged fontan reconstruction assessed by magnetic resonance imaging. J Am Coll Cardiol 1996; 28: 212–221.
77. Scheurer, MA, Hill, EG, Vasuki, N, et al. Survival after bidirectional cavopulmonary anastomosis: Analysis of preoperative risk factors. J Thorac Cardiovasc Surg 2007; 134: 82–89; 89 e81–82.
78. Galantowicz, M, Cheatham, JP, Phillips, A, et al. Hybrid approach for hypoplastic left heart syndrome: Intermediate results after the learning curve. Ann Thorac Surg 2008; 85: 2063–2070; discussion 2070–2061.
79. Brown, DW, Gauvreau, K, Moran, AM, et al. Clinical outcomes and utility of cardiac catheterization prior to superior cavopulmonary anastomosis. J Thorac Cardiovasc Surg 2003; 126: 272–281.
80. Dave, H, Rosser, B, Knirsch, W, Hubler, M, Pretre, R, Kretschmar, O. Hybrid approach for hypoplastic left heart syndrome and its variants: the fate of the pulmonary arteries. Eur J Cardiothorac Surg 2014; 46: 14–19.
81. Davies, RR, Radtke, WA, Klenk, D, Pizarro, C. Bilateral pulmonary arterial banding results in an increased need for subsequent pulmonary artery interventions. J Thorac Cardiovasc Surg 2014; 147: 706–712.
82. Eagam, M, Loomba, RS, Pelech, AN, Tweddell, JS, Kirkpatrick, E. Predicting the need for neoaortic arch intervention in infants with hypoplastic left heart syndrome through the Glenn procedure. Pediatr Cardiol 2017; 38: 70–76.
83. Brown, DW, Gauvreau, K, Powell, AJ, et al. Cardiac magnetic resonance versus routine cardiac catheterization before bidirectional Glenn anastomosis: Long-term follow-up of a prospective randomized trial. J Thorac Cardiovasc Surg 2013; 146: 1172–1178.
84. Han, BK, Vezmar, M, Lesser, JR, et al. Selective use of cardiac computed tomography angiography: An alternative diagnostic modality before second-stage single ventricle palliation. J Thorac Cardiovasc Surg 2014; 148: 1548–1554.
85. Menon, SC, McCandless, RT, Mack, GK, et al. Clinical outcomes and resource use for infants with hypoplastic left heart syndrome during bidirectional Glenn: Summary from the joint council for congenital heart disease national pediatric cardiology quality improvement collaborative registry. Pediatr Cardiol 2013; 34: 143–148.
86. Baker-Smith, CM, Goldberg, SW, Rosenthal, GL. Predictors of prolonged hospital length of stay following stage ii palliation of hypoplastic left heart syndrome (and variants): Analysis of the national pediatric cardiology quality improvement collaborative (npc-qic) database. Pediatr Cardiol 2015; 36: 1630–1641.
87. Lee, TM, Aiyagari, R, Hirsch, JC, Ohye, RG, Bove, EL, Devaney, EJ. Risk factor analysis for second-stage palliation of single ventricle anatomy. Ann Thorac Surg 2012; 93: 614–618. .
88. Redington, AN, Penny, D, Shinebourne, EA. Pulmonary blood flow after total cavopulmonary shunt. Br Heart J 1991; 65: 213–217.
89. Lofland, GK. The enhancement of hemodynamic performance in fontan circulation using pain free spontaneous ventilation. Eur J Cardiothorac Surg 2001; 20: 114–118; discussion 118–119.
90. Huang, J, Zhou, Y, Zhu, D. Systemic haemodynamics and regional tissue oxygen saturation after bidirectional cavopulmonary shunt: Positive pressure ventilation versus spontaneous breathing. Interact Cardiovasc Thorac Surg 2016; 23: 235–239.
91. Bronicki, RA, Anas, NG. Cardiopulmonary interaction. Pediatr Crit Care Med 2009; 10: 313–322.
92. Bronicki, RA, Penny, DJ, Anas, NG, Fuhrman, B. Cardiopulmonary interactions. Pediatr Crit Care Med 2016; 17: S182–S193.
93. Li, J, Hoskote, A, Hickey, C, Stephens, D, et al. Effect of carbon dioxide on systemic oxygenation, oxygen consumption, and blood lactate levels after bidirectional superior cavopulmonary anastomosis. Crit Care Med 2005; 33: 984–989.
94. Jolley, M, Thiagarajan, RR, Barrett, CS, et al. Extracorporeal membrane oxygenation in patients undergoing superior cavopulmonary anastomosis. J Thorac Cardiovasc Surg 2014; 148: 1512–1518.
95. Booth, KL, Roth, SJ, Thiagarajan, RR, Almodovar, MC, del Nido, PJ, Laussen, PC. Extracorporeal membrane oxygenation support of the fontan and bidirectional Glenn circulations. Ann Thorac Surg 2004; 77: 1341–1348.
96. Gomez, D, Duffy, V, Hersey, D, et al. Extracorporeal membrane oxygenation outcomes after the comprehensive stage ii procedure in patients with single ventricles. Artif Organs 2017; 41: 66–70.
97. Niebler, RA, Shah, TK, Mitchell, ME, et al. Ventricular assist device in single-ventricle heart disease and a superior cavopulmonary anastomosis. Artif Organs 2016; 40: 180–184.
98. Fontan, F, Baudet, E. Surgical repair of tricuspid atresia. Thorax 1971; 26: 240–248.
99. Lemler, MS, Scott, WA, Leonard, SR, Stromberg, D, Ramaciotti, C. Fenestration improves clinical outcome of the fontan procedure: A prospective, randomized study. Circulation 2002; 105: 207–212.
100. Sinha, P, Zurakowski, D, He, D, et al. Intra/extracardiac fenestrated modification leads to lower incidence of arrhythmias after the fontan operation. J Thorac Cardiovasc Surg 2013; 145: 678–682.
101. Forsdick, V, Iyengar, AJ, Carins, T, et al. Unsatisfactory early and late outcomes after fontan surgery delayed to adolescence and adulthood. Semin Thorac Cardiovasc Surg 2015; 27: 168–174.
102. Garofalo, CA, Cabreriza, SE, Quinn, TA, et al. Ventricular diastolic stiffness predicts perioperative morbidity and duration of pleural effusions after the fontan operation. Circulation 2006; 114: I56–I61.
103. Fontan, F, Fernandez, G, Costa, F, et al. The size of the pulmonary arteries and the results of the fontan operation. J Thorac Cardiovasc Surg 1989; 98: 711–719; discussion 719–724.
104. Knott-Craig, CJ, Julsrud, PR, Schaff, HV, Puga, FJ, Danielson, GK. Pulmonary artery size and clinical outcome after the modified fontan operation. Ann Thorac Surg 1993; 55: 646–651.
105. Fogel, MA, Pawlowski, TW, Whitehead, KK, et al. Cardiac magnetic resonance and the need for routine cardiac catheterization in single ventricle patients prior to fontan: a comparison of 3 groups: Pre-fontan cmr versus cath evaluation. J Am Coll Cardiol 2012; 60: 1094–1102.
106. Azakie, A, Merklinger, SL, Williams, WG, Van Arsdell, GS, Coles, JG, Adatia, I. Improving outcomes of the fontan operation in children with atrial isomerism and heterotaxy syndromes. Ann Thorac Surg 2001; 72: 1636–1640.
107. Bartz, PJ, Driscoll, DJ, Dearani, JA, et al. Early and late results of the modified fontan operation for heterotaxy syndrome 30 years of experience in 142 patients. J Am Coll Cardiol 2006; 48: 2301–2305.
108. Gentles, TL, Mayer, JE Jr., Gauvreau, K, et al. Fontan operation in five hundred consecutive patients: Factors influencing early and late outcome. J Thorac Cardiovasc Surg 1997; 114: 376–391.
109. Ballweg, JA, Dominguez, TE, Ravishankar, C, et al. A contemporary comparison of the effect of shunt type in hypoplastic left heart syndrome on the hemodynamics and outcome at fontan completion. J Thorac Cardiovasc Surg 2010; 140: 537–544.
110. Hakacova, N, Lakomy, M, Kovacikova, L. Arrhythmias after fontan operation: comparison of lateral tunnel and extracardiac conduit. J Electrocardiol 2008; 41: 173–177.
111. Shekerdemian, LS, Bush, A, Shore, DF, Lincoln, C, Redington, AN. Cardiopulmonary interactions after fontan operations: Augmentation of cardiac output using negative pressure ventilation. Circulation 1997; 96: 3934–3942.
112. Penny, DJ, Redington, AN. Doppler echocardiographic evaluation of pulmonary blood flow after the fontan operation: The role of the lungs. Br Heart J 1991; 66: 372–374.
113. Mutsuga, M, Quinonez, LG, Mackie, AS, et al. Fast-track extubation after modified fontan procedure. J Thorac Cardiovasc Surg 2012; 144: 547–552.
114. Salvin, JW, Scheurer, MA, Laussen, PC, et al. Factors associated with prolonged recovery after the fontan operation. Circulation 2008; 118: S171–S176.
115. Imielski, BR, Niebler, RA, Kindel, SJ, Woods, RK. Heartware ventricular assist device implantation in patients with fontan physiology. Artif Organs 2017; 41: 40–46.
116. Throckmorton, AL, Lopez-Isaza, S, Downs, EA, Chopski, SG, Gangemi, JJ, Moskowitz, W. A viable therapeutic option: Mechanical circulatory support of the failing fontan physiology. Pediatr Cardiol 2013; 34: 1357–1365.
117. Woods, RK, Ghanayem, NS, Mitchell, ME, Kindel, S, Niebler, RA. Mechanical circulatory support of the fontan patient. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2017; 20: 20–27.
118. Arnaoutakis, GJ, Blitzer, D, Fuller, S, et al. Mechanical circulatory support as bridge to transplantation for the failing single ventricle. Ann Thorac Surg 2017; 103: 193–197.
119. Giridharan, GA, Ising, M, Sobieski, MA, et al. Cavopulmonary assist for the failing fontan circulation: Impact of ventricular function on mechanical support strategy. ASAIO J 2014; 60: 707–715.
120. Rychik, J. Forty years of the fontan operation: a failed strategy. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2010; 13: 96–100.
121. Alsoufi, B, Mahle, WT, Manlhiot, C, et al. Outcomes of heart transplantation in children with hypoplastic left heart syndrome previously palliated with the norwood procedure. J Thorac Cardiovasc Surg 2016; 151: 167–174; 175 e161–162.
122. Kulkarni, A, Neugebauer, R, Lo, Y, et al. Outcomes and risk factors for listing for heart transplantation after the norwood procedure: An analysis of the single ventricle reconstruction trial. J Heart Lung Transplant 2016; 35: 306–311.
123. Almond, CS, Gauvreau, K, Canter, CE, Rajagopal, SK, Piercey, GE, Singh, TP. A risk-prediction model for in-hospital mortality after heart transplantation in us children. Am J Transplant 2012; 12: 1240–1248.
124. Weinstein, S, Bello, R, Pizarro, C, et al. The use of the berlin heart excor in patients with functional single ventricle. J Thorac Cardiovasc Surg 2014; 147: 697–704; discussion 704-695.
125. Rossano, JW, Woods, RK, Berger, S, et al. Mechanical support as failure intervention in patients with cavopulmonary shunts (mfics): Rationale and aims of a new registry of mechanical circulatory support in single ventricle patients. Congenit Heart Dis 2013; 8: 182–186.
126. O’Connor, MJ, Pahl, E, Webber, SA, Rossano, JW. Recent advances in heart transplant immunology: The role of antibodies. Prog Pediatr Cardiol 2016; 43: 81–85.
127. Shaddy, RE, Hunter, DD, Osborn, KA, et al. Prospective analysis of hla immunogenicity of cryopreserved valved allografts used in pediatric heart surgery. Circulation 1996; 94: 1063–1067.
128. Tambur, AR, Pamboukian, SV, Costanzo, MR, et al. The presence of hla-directed antibodies after heart transplantation is associated with poor allograft outcome. Transplantation 2005; 80: 1019–1025.
129. Rossano, JW, Morales, DL, Zafar, F, et al. Impact of antibodies against human leukocyte antigens on long-term outcome in pediatric heart transplant patients: An analysis of the united network for organ sharing database. The Journal of thoracic and cardiovascular surgery 2010; 140: 694–699; 699 e691–692.
130. Tran, A, Fixler, D, Huang, R, Meza, T, Lacelle, C, Das, BB. Donor-specific hla alloantibodies: Impact on cardiac allograft vasculopathy, rejection, and survival after pediatric heart transplantation. J Heart Lung Transplant 2016; 35: 87–91.
131. Colvin, MM, Cook, JL, Chang, P, et al. Antibody-mediated rejection in cardiac transplantation: Emerging knowledge in diagnosis and management: A scientific statement from the american heart association. Circulation 2015; 131: 1608–1639.
132. Everitt, MD, Boyle, GJ, Schechtman, KB, et al. Early survival after heart transplant in young infants is lowest after failed single-ventricle palliation: a multi-institutional study. J Heart Lung Transplant 2012; 31: 509–516.
133. Kovach, JR, Naftel, DC, Pearce, FB, et al. Comparison of risk factors and outcomes for pediatric patients listed for heart transplantation after bidirectional Glenn and after Fontan: an analysis from the pediatric heart transplant study. J Heart Lung Transplant 2012; 31: 133–139.
134. Griffiths, ER, Kaza, AK, Wyler von Ballmoos, MC, et al. Evaluating failing fontans for heart transplantation: Predictors of death. Ann Thorac Surg 2009; 88: 558–563; discussion 563–554.
135. Simpson, KE, Pruitt, E, Kirklin, JK, et al. Fontan patient survival after pediatric heart transplantation has improved in the current era. Ann Thorac Surg 2017; 103: 1315–1320.
136. Miller, JR, Simpson, KE, Epstein, DJ, et al. Improved survival after heart transplant for failed fontan patients with preserved ventricular function. J Heart Lung Transplant 2016; 35: 877–883.
137. Mehra, MR, Canter, CE, Hannan, MM, et al. The 2016 international society for heart lung transplantation listing criteria for heart transplantation: a 10-year update. J Heart Lung Transplant 2016; 35: 1–23.